Thermo Fisher Scientific Inc. TMO
Set alert
697.90 USD +15.25 +2.23%
As of Nov 3, 2:56 PM ET
672.00 Day range 700.19
438.34 52-week range 709.18
- YTD
- +20.44%
- 1 year
- +23.55%
- Open
- 677.92
- Prev close
- 682.65
- Mkt cap
- 258.60B
- Vol
- 866.91K
- Avg vol
- 2.09M
- EPS
- 18.96
- P/E
- 36.81
- Div yield
- 0.27%
More statistics
- Low
- 672.00
- High
- 700.19
- Forward P/E
- 24.57
- Beta
- 0.84
- Short ratio
- 1.98
- Inst. own
- 93.46%
- Dividend
- 1.88
- Ex-div date
- Sep 14, 2026
- Earnings
- Feb 4, 2027
- 50-d avg
- 654.65
- 200-d avg
- 551.37
- 1y target
- 752.12
6M chart
Events in this range
- Jun 15, 2026Dividend: 0.47
- Jul 23, 2026Earnings: 6.03; estimate 5.72; surprise 5.42%
- Sep 15, 2026Dividend: 0.47
- Oct 21, 2026Earnings: 6.68; estimate 6.4; surprise 4.37%
- Oct 22, 2026Rating: Stifel · Buy → Buy
- Oct 22, 2026Rating: TD Cowen · Buy → Buy
- Oct 22, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Oct 22, 2026Rating: Barclays · Overweight → Overweight
- Oct 23, 2026Rating: Citigroup · Buy → Buy
- Oct 30, 2026Rating: Argus Research · Buy → Buy
Signals (29)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 2026 | 1 day ago |
| MACD: Buy Signal | Oct 28, 2026 | 6 days ago |
| MACD: Sell Signal | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| RSI: Overbought | Sep 23, 2026 | 1 month ago |
| RSI: Overbought | Sep 17, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 20, 2026 | 2 months ago |
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| RSI: Overbought | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 23, 2026 | 3 months ago |
| RSI: Overbought | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 21, 2026 | 3 months ago |
| RSI: Overbought | Jul 16, 2026 | 3 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
Newest 20 of 29.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 752.12 +7.8% upside
Now 697.90
- Target (low)
- 590.00
- Target (mean)
- 752.12
- Target (high)
- 830.00
Ratings (0m) 27 23 buy · 3 hold · 1 sell
- Strong buy3
- Buy20
- Hold3
- Sell0
- Strong sell1
Recommendation trend
- This month 27
- 1 month ago 28
- 2 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 7.14 | 7.00 – 7.34 | 6.57 | +8.6% | 12.86B | +5.3% | 21 |
| Next quarter | 6.05 | 5.64 – 6.53 | 5.44 | +11.3% | 11.74B | +6.7% | 13 |
| Current year | 25.28 | 25.15 – 25.40 | 22.87 | +10.5% | 48.00B | +7.7% | 26 |
| Next year | 27.77 | 27.02 – 29.31 | 25.28 | +9.9% | 50.53B | +5.3% | 27 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Argus Research | Maintained | Buy | Buy |
| Oct 23, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 22, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 22, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 22, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 22, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 22, 2026 | Baird | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Sep 3, 2026 | CLSA | Initiated | — | Outperform |
| Jul 27, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Jul 27, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 24, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jun 11, 2026 | Piper Sandler | Initiated | — | Neutral |
| Jun 3, 2026 | HSBC | Downgrade | Buy | Hold |
| May 8, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 24, 2026 | Stifel | Maintained | Buy | Buy |
| Apr 24, 2026 | Baird | Maintained | Outperform | Outperform |
| Apr 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jan 30, 2026 | Citigroup | Maintained | Buy | Buy |
| Jan 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jan 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 9, 2026 | Stifel | Maintained | Buy | Buy |
| Jan 7, 2026 | TD Cowen | Maintained | Buy | Buy |
| Dec 15, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Dec 11, 2025 | Citigroup | Upgrade | Neutral | Buy |